These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9787978)

  • 1. Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): a multicentre trial in central Europe.
    Breza J; Dzurny O; Borowka A; Hanus T; Petrik R; Blane G; Chadha-Boreham H
    Curr Med Res Opin; 1998; 14(3):127-39. PubMed ID: 9787978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pygeum africanum for benign prostatic hyperplasia.
    Wilt T; Ishani A; Mac Donald R; Rutks I; Stark G
    Cochrane Database Syst Rev; 2002; 1998(1):CD001044. PubMed ID: 11869585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of once and twice daily dosage forms of Pygeum africanum extract in patients with benign prostatic hyperplasia: a randomized, double-blind study, with long-term open label extension.
    Chatelain C; Autet W; Brackman F
    Urology; 1999 Sep; 54(3):473-8. PubMed ID: 10475357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of Pygeum africanum extract in the medical therapy of urination disorders due to benign prostatic hyperplasia: evaluation of objective and subjective parameters. A placebo-controlled double-blind multicenter study].
    Barlet A; Albrecht J; Aubert A; Fischer M; Grof F; Grothuesmann HG; Masson JC; Mazeman E; Mermon R; Reichelt H
    Wien Klin Wochenschr; 1990 Nov; 102(22):667-73. PubMed ID: 1702916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis.
    Ishani A; MacDonald R; Nelson D; Rutks I; Wilt TJ
    Am J Med; 2000 Dec; 109(8):654-64. PubMed ID: 11099686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tadenan (Pygeum africanum extract) in the treatment of patients with benign prostatic hyperplasia].
    Urologiia; 2004; (5):70-2. PubMed ID: 15560171
    [No Abstract]   [Full Text] [Related]  

  • 7. Phytotherapy for benign prostatic hyperplasia.
    Wilt TJ; Ishani A; Rutks I; MacDonald R
    Public Health Nutr; 2000 Dec; 3(4A):459-72. PubMed ID: 11276294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of treatment with Pygeum africanum in patients with lower urinary tract symptoms and benign prostatic hyperplasia: a cross-sectional study in the real-world clinical practice in Spain (The PROFIT Study)].
    Cambronero J; Osca-García JM; Merino-Salas S; Miguel JM; Borralleras C; López-Alcina E
    Arch Esp Urol; 2022 Apr; 75(3):219-227. PubMed ID: 35435166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tamsulosin hydrochloride on lower urinary tract symptoms and quality of life in patients with benign prostatic hyperplasia. Evaluation using bother score.
    Yoshida M; Sugiyama Y; Masunaga K; Maeda Y; Satoji Y; Nagata T; Inadome A
    Drugs Today (Barc); 2007 Jun; 43 Suppl B():1-7. PubMed ID: 17612712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Murraya koenigii- and Tribulus terrestris-based oral formulation versus tamsulosin in the treatment of benign prostatic hyperplasia in men aged >50 years: a double-blind, double-dummy, randomized controlled trial.
    Sengupta G; Hazra A; Kundu A; Ghosh A
    Clin Ther; 2011 Dec; 33(12):1943-52. PubMed ID: 22177370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urological and sexual evaluation of treatment of benign prostatic disease using Pygeum africanum at high doses].
    Carani C; Salvioli V; Scuteri A; Borelli A; Baldini A; Granata AR; Marrama P
    Arch Ital Urol Nefrol Androl; 1991 Sep; 63(3):341-5. PubMed ID: 1723220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens.
    Levin RM; Das AK
    Urol Res; 2000 Jun; 28(3):201-9. PubMed ID: 10929430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the efficiency of a combination of Pygeum africanum and stinging nettle (Urtica dioica) extracts in treating benign prostatic hyperplasia (BPH): double-blind, randomized, placebo controlled trial.
    Melo EA; Bertero EB; Rios LA; Mattos D
    Int Braz J Urol; 2002; 28(5):418-25. PubMed ID: 15748367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.
    Porst H; Kim ED; Casabé AR; Mirone V; Secrest RJ; Xu L; Sundin DP; Viktrup L;
    Eur Urol; 2011 Nov; 60(5):1105-13. PubMed ID: 21871706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tadalafil Improves Symptoms, Erectile Function and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (KYU-PRO Study).
    Takahashi R; Miyazato M; Nishii H; Sumino Y; Takayama K; Onzuka M; Oshiro T; Saito S; Fujimoto N; Mimata H; Eto M
    Low Urin Tract Symptoms; 2018 Jan; 10(1):76-83. PubMed ID: 29341501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.
    Coulson S; Rao A; Beck SL; Steels E; Gramotnev H; Vitetta L
    Complement Ther Med; 2013 Jun; 21(3):172-9. PubMed ID: 23642948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
    Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
    BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe].
    Chapple ChR; Montorsi F; Tammela TL; Wirth M; Koldewijn E; Fernandez Fernandez E
    Urologiia; 2012; (5):38-42, 44-5. PubMed ID: 23342615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.
    Chapple CR; Montorsi F; Tammela TL; Wirth M; Koldewijn E; Fernández Fernández E;
    Eur Urol; 2011 Mar; 59(3):342-52. PubMed ID: 21109344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.